AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 272: R1990-R1997, 1997;
0363-6119/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y. H.
Right arrow Articles by Lang, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y. H.
Right arrow Articles by Lang, C. H.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 272, Issue 6 1990-R1997, Copyright © 1997 by American Physiological Society


ARTICLES

Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-1

Y. H. Li, J. Fan and C. H. Lang
Department of Surgery, State University of New York at Stony Brook 11794-8191, USA.

The purpose of the present study was to determine whether endogenous elevations in glucocorticoids mediate the changes in insulin-like growth factor (IGF) 1 and IGF binding protein (IGFBP) 1 levels in plasma and tissues observed after in vivo administration of lipopolysaccharide (LPS). In overnight-fasted male rats LPS injected via the tail vein decreased the IGF-I concentration in plasma, liver, and skeletal muscle (30-45%) and increased IGF-I content in kidney (approximately 3-fold). LPS also decreased IGF-I mRNA abundance in liver and muscle and increased gene expression in kidney. Concomitantly, IGFBP-1 levels in plasma, liver, and muscle were markedly elevated by LPS. All these changes were associated with a greater than fourfold elevation in plasma corticosterone. Pretreatment of rats with the glucocorticoid receptor antagonist RU-486 completely prevented or blunted the LPS-induced changes in IGF-I content in plasma, liver, muscle, and kidney. In liver and muscle RU-486 significantly attenuated the reduction in IGF-I mRNA abundance produced by LPS, but in kidney the LPS-induced increase in IGF-I mRNA was still evident. In contrast, pretreatment with RU-486 did not prevent or attenuate the LPS-induced increase in IGFBP-1 levels in plasma, liver, or muscle. These data suggest that glucocorticoids play a major role in regulating IGF-I mRNA and peptide content in tissues in response to LPS, but the increased IGFBP-1 in blood and tissues induced by LPS appears largely glucocorticoid independent.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. H. Lang, B. J. Krawiec, D. Huber, J. M. McCoy, and R. A. Frost
Sepsis and inflammatory insults downregulate IGFBP-5, but not IGFBP-4, in skeletal muscle via a TNF-dependent mechanism
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R963 - R972.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Q. Hong-Brown, C. R. Brown, R. N. Cooney, R. A. Frost, and C. H. Lang
Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E63 - E72.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Yumet, M. L. Shumate, P. Bryant, C.-M. Lin, C. H. Lang, and R. N. Cooney
Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis
Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E472 - E481.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. H. Lang, G. J. Nystrom, and R. A. Frost
Burn-induced changes in IGF-I and IGF-binding proteins are partially glucocorticoid dependent
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R207 - R215.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Fedele, C. H. Lang, and P. A. Farrell
Immunization against IGF-I prevents increases in protein synthesis in diabetic rats after resistance exercise
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E877 - E885.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Fedele, T. C. Vary, and P. A Farrell
Plasticity in Skeletal, Cardiac, and Smooth Muscle: Selected Contribution: IGF-I antibody prevents increases in protein synthesis in epitrochlearis muscles from refed, diabetic rats
J Appl Physiol, March 1, 2001; 90(3): 1166 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Fedele, J. M. Hernandez, C. H. Lang, T. C. Vary, S. R. Kimball, L. S. Jefferson, and P. A. Farrell
Severe diabetes prohibits elevations in muscle protein synthesis after acute resistance exercise in rats
J Appl Physiol, January 1, 2000; 88(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. A. Farrell, M. J. Fedele, J. Hernandez, J. D. Fluckey, J. L. Miller III, C. H. Lang, T. C. Vary, S. R. Kimball, and L. S. Jefferson
Hypertrophy of skeletal muscle in diabetic rats in response to chronic resistance exercise
J Appl Physiol, September 1, 1999; 87(3): 1075 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. A. Farrell, M. J. Fedele, T. C. Vary, S. R. Kimball, C. H. Lang, and L. S. Jefferson
Regulation of protein synthesis after acute resistance exercise in diabetic rats
Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E721 - E727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online